SCM
Sio Capital Management Portfolio holdings
AUM
$249M
This Quarter Return
+61.82%
1 Year Return
+117.71%
3 Year Return
+238.99%
5 Year Return
+411.91%
10 Year Return
+912.87%
AUM
$457M
AUM Growth
+$457M
(+1.3%)
Cap. Flow
-$83.6M
Cap. Flow
% of AUM
-18.3%
Top 10 Holdings %
Top 10 Hldgs %
36.18%
Holding
114
New
24
Increased
11
Reduced
44
Closed
23
Top Buys
| 1 |
SPRB
Spruce Biosciences, Inc. Common Stock
SPRB
|
$15.5M |
| 2 |
AstraZeneca
AZN
|
$13.1M |
| 3 |
Universal Health Services
UHS
|
$11.1M |
| 4 |
Sanofi
SNY
|
$10.7M |
| 5 |
Amgen
AMGN
|
$9.2M |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
$17M |
| 2 |
McKesson
MCK
|
$12.3M |
| 3 |
Molina Healthcare
MOH
|
$10M |
| 4 |
AMN Healthcare
AMN
|
$9.67M |
| 5 |
Cardinal Health
CAH
|
$8.96M |
Sector Composition
| 1 | Healthcare | 87.36% |
| 2 | Technology | 1.15% |
| 3 | Consumer Staples | 0.82% |
| 4 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
United Therapeutics
UTHR
$13.8B
| $5.88M | 1.2% |
38,734
-20,476
| -35% | -$3.11M |
|
27
ASGN Inc
ASGN
$2.38B
| $5.27M | 1.08% |
+63,077
| New | +$5.27M |
|
|
RDUS
28
DELISTED
Radius Health, Inc.
RDUS
| $5.24M | 1.07% |
293,157
-401,613
| -58% | -$7.17M |
|
29
ESSA Pharma
EPIX
$11.3M
| $5.17M | 1.06% |
433,023
-223,020
| -34% | -$2.66M |
|
30
Mersana Therapeutics
MRSN
$36.5M
| $4.92M | 1.01% |
184,959
-106,822
| -37% | -$2.84M |
|
31
Cellectar Biosciences
CLRB
$15.5M
| $4.85M | 0.99% |
2,331,123
+966,666
| +71% | +$2.01M |
|
32
Ionis Pharmaceuticals
IONS
$9.16B
| $4.58M | 0.94% |
+81,026
| New | +$4.58M |
|
33
Ardelyx
ARDX
$1.53B
| $4.46M | 0.91% |
689,321
-65,000
| -9% | -$421K |
|
34
Varex Imaging
VREX
$480M
| $4.45M | 0.91% |
266,740
+151,346
| +131% | +$2.52M |
|
|
ARNA
35
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $4.44M | 0.91% |
57,738
-14,015
| -20% | -$1.08M |
|
|
SYNH
36
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $4.43M | 0.91% |
65,000
-46,285
| -42% | -$3.15M |
|
37
Kura Oncology
KURA
$686M
| $4.32M | 0.88% |
132,283
+101,000
| +323% | +$3.3M |
|
38
Cross Country Healthcare
CCRN
$438M
| $4.3M | 0.88% |
485,164
+83,929
| +21% | +$744K |
|
|
CHAQ.U
39
DELISTED
Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one
CHAQ.U
| $4.24M | 0.87% |
400,000
| – | – |
|
40
Larimar Therapeutics
LRMR
$310M
| $4.04M | 0.83% |
188,661
-111,930
| -37% | -$2.4M |
|
|
41
Molina Healthcare
MOH
$9.8B
| $3.99M | 0.82% |
18,763
-47,011
| -71% | -$10M |
|
|
GWPH
42
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $3.9M | 0.8% |
33,801
+13,300
| +65% | +$1.53M |
|
43
Integer Holdings
ITGR
$3.78B
| $3.79M | 0.78% |
46,699
-82,677
| -64% | -$6.71M |
|
44
Syndax Pharmaceuticals
SNDX
$1.41B
| $3.78M | 0.77% |
170,142
+165,346
| +3,448% | +$3.68M |
|
|
NTUS
45
DELISTED
Natus Medical Inc
NTUS
| $3.74M | 0.77% |
186,833
+83,008
| +80% | +$1.66M |
|
46
Herbalife
HLF
$1.01B
| $3.73M | 0.76% |
77,660
-10,940
| -12% | -$526K |
|
47
Viking Therapeutics
VKTX
$3.09B
| $3.43M | 0.7% |
609,780
-100,000
| -14% | -$563K |
|
|
CBAY
48
DELISTED
Cymabay Therapeutics
CBAY
| $3.37M | 0.69% |
587,339
-571,897
| -49% | -$3.28M |
|
49
Orchestra BioMed
OBIO
$147M
| $3.2M | 0.66% |
250,000
| – | – |
|
|
EUCRU
50
DELISTED
Eucrates Biomedical Acquisition Corp. Unit
EUCRU
| $3.2M | 0.65% |
+300,000
| New | +$3.2M |
|